Taizhou Hanzhong Pharmaceutical

Taizhou Hanzhong Pharmaceutical is a Chinese pharmaceutical company headquartered in the Toumen Port Economic Development Zone of Taizhou, Zhejiang Province. Established in 2003, the company specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced chemical intermediates. Its primary therapeutic focus areas include cardiovascular health, specifically statins, and gastroenterology, specifically proton pump inhibitors. The company operates modern manufacturing facilities that adhere to international Good Manufacturing Practice (GMP) standards, enabling it to supply products to both domestic and global markets. Taizhou Hanzhong Pharmaceutical is recognized for its technical expertise in complex organic synthesis and its role as a reliable partner in the pharmaceutical supply chain.